Bisphosphonate class drugs

6 results

  • alendronate

    (ALENDRONATE SODIUM)
    Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
    Alendronate sodium tablets are indicated for treating and preventing osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, treating glucocorticoid-induced osteoporosis, and treating Paget’s disease of bone. Use should be periodically re-evaluated, particularly for low-risk fracture patients after 3 to 5 years.
    Medication Details
    Drug Interactions

  • alendronate sodium

    (Alendronate Sodium)
    Hikma Pharmaceuticals USA Inc.
    Alendronate sodium is indicated for the treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It reduces fracture incidence, though the optimal treatment duration hasn't been established, requiring periodic re-evaluation of the need for continued therapy.
    Medication Details
    Drug Interactions

  • ibandronate sodium

    (Ibandronate sodium)
    Dr. Reddy's Laboratories Limited
    Ibandronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. They increase bone mineral density and reduce vertebral fractures. Continued therapy needs periodic evaluation, especially after 3 to 5 years for low-risk patients.
    Medication Details
    Drug Interactions

  • ibandronate sodium

    (IBANDRONATE SODIUM)
    Apotex Corp
    Ibandronate sodium tablets are indicated for the treatment and prevention of postmenopausal osteoporosis, increasing bone mineral density and reducing vertebral fractures. Optimal duration of use is not established; reevaluation of therapy need is recommended after 3-5 years, especially for low-risk fracture patients.
    Medication Details
    Drug Interactions

  • ibandronate sodium

    (IBANDRONATE SODIUM)
    Macleods Pharmaceuticals Limited
    Ibandronate sodium tablets are indicated for the treatment and prevention of postmenopausal osteoporosis, increasing bone mineral density and reducing the risk of vertebral fractures. Safety and effectiveness are established for up to three years, with periodic re-evaluation of therapy needed for ongoing treatment.
    Medication Details
    Drug Interactions

  • ibandronate sodium

    (ibandronate sodium)
    Apotex Corp.
    Ibandronate sodium injection is indicated for treating osteoporosis in postmenopausal women, enhancing bone mineral density and decreasing vertebral fracture incidence. Its safety and effectiveness are primarily based on one-year clinical data, with ongoing assessment of therapy necessity recommended for patients.
    Medication Details
    Drug Interactions